VitaeBiomedical Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
VITAE Biomedical offers a Urine‑based Lung Cancer ELISA Reagent Kit, which uses dual highly specific antibodies in a sandwich assay to detect lung cancer–associated proteins in urine. The test shows high sensitivity and specificity, is CE‑certified in the
Founded Year
2017
Unified Business No.
55623255
Status
Active
Number of Employees
0
Total Paid-in
Capital
115,102,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
VITAE Biomedical Co., Ltd., founded in 2019, is a molecular diagnostics biotech company focused on developing fast, accurate, and cost-effective automated cancer screening technologies. Their R&D team, primarily from Academia Sinica, aims to bring real-world clinical diagnostic tools to early disease detection and health management.
